Verrica Pharmaceuticals Correlations

VRCA Stock

USD 1.81 0.13 6.70%

The current 90-days correlation between Verrica Pharmaceuticals and LianBio ADR is -0.05 (i.e., Good diversification). The correlation of Verrica Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Verrica Pharmaceuticals Correlation With Market

Average diversification

The correlation between Verrica Pharmaceuticals and DJI is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verrica Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For information on how to trade Verrica Stock refer to our How to Trade Verrica Stock guide.

Moving together with Verrica Stock

0.66	DYAI	Dyadic International	Pair Corr
0.71	ERNA	Eterna Therapeutics	Pair Corr
0.94	ESPR	Esperion Therapeutics	Pair Corr
0.71	BNR	Burning Rock Biotech	Pair Corr
0.9	DNA	Ginkgo Bioworks Holdings Trending	Pair Corr
0.72	MRK	Merck Company Sell-off Trend	Pair Corr
0.81	PTN	Palatin Technologies Earnings Call This Week	Pair Corr
0.7	HEPA	Hepion Pharmaceuticals	Pair Corr
0.65	CYTHW	Cyclo Therapeutics	Pair Corr
0.83	LPCN	Lipocine	Pair Corr
0.62	MBIO	Mustang Bio	Pair Corr
0.77	MNMD	Mind Medicine Downward Rally	Pair Corr
0.72	OCEA	Ocean Biomedical	Pair Corr
0.91	ONCT	Oncternal Therapeutics	Pair Corr
0.7	RANI	Rani Therapeutics	Pair Corr
0.75	ABCL	Abcellera Biologics	Pair Corr

Moving against Verrica Stock

0.92	SNY	Sanofi ADR	Pair Corr
0.9	XGN	Exagen Inc	Pair Corr
0.87	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.76	SLS	Sellas Life Sciences	Pair Corr
0.76	WAT	Waters	Pair Corr
0.34	INBX	Inhibrx Symbol Change	Pair Corr
0.87	REGN	Regeneron Pharmaceuticals	Pair Corr
0.78	BIAFW	BioAffinity Technologies	Pair Corr
0.53	RGEN	Repligen	Pair Corr
0.51	NUVL	Nuvalent Trending	Pair Corr
0.45	AMGN	Amgen Inc	Pair Corr
0.35	ABSI	Absci Corp	Pair Corr

Related Correlations Analysis

	LIAN	IVA	EWTX	VIGL	CNTB	ABOS	ETON	NUVB	ELDN	VRNA
LIAN		-0.52	-0.08	-0.14	-0.31	0.58	-0.01	0.08	0.5	0.35	LIAN
IVA	-0.52		0.07	0.5	0.52	-0.32	-0.6	0.09	-0.28	-0.79	IVA
EWTX	-0.08	0.07		0.13	0.06	0.14	0.19	0.11	0.02	0.16	EWTX
VIGL	-0.14	0.5	0.13		0.41	0.31	-0.5	0.75	0.11	-0.52	VIGL
CNTB	-0.31	0.52	0.06	0.41		-0.27	-0.24	0.17	-0.24	-0.46	CNTB
ABOS	0.58	-0.32	0.14	0.31	-0.27		-0.13	0.64	0.79	0.21	ABOS
ETON	-0.01	-0.6	0.19	-0.5	-0.24	-0.13		-0.29	-0.04	0.83	ETON
NUVB	0.08	0.09	0.11	0.75	0.17	0.64	-0.29		0.39	-0.21	NUVB
ELDN	0.5	-0.28	0.02	0.11	-0.24	0.79	-0.04	0.39		0.25	ELDN
VRNA	0.35	-0.79	0.16	-0.52	-0.46	0.21	0.83	-0.21	0.25		VRNA
	LIAN	IVA	EWTX	VIGL	CNTB	ABOS	ETON	NUVB	ELDN	VRNA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

VRNA	+ 0.83	ETON
ELDN	+ 0.79	ABOS
NUVB	+ 0.75	VIGL
NUVB	+ 0.64	ABOS
ABOS	+ 0.58	LIAN
CNTB	+ 0.52	IVA

High negative correlations

VRNA	- 0.79	IVA
ETON	- 0.6	IVA
VRNA	- 0.52	VIGL
IVA	- 0.52	LIAN
ETON	- 0.5	VIGL
VRNA	- 0.46	CNTB

Risk-Adjusted Indicators

There is a big difference between Verrica Stock performing well and Verrica Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Verrica Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
LIAN	2.99	0.23	0.01	(0.20)	3.34	(3.44)	6.76	(5.00)	20.98
IVA	2.56	(0.33)	0.00	(4.69)	0.00	0.00	6.36	(5.02)	21.92
EWTX	4.29	0.85	0.23	0.51	3.71	(5.00)	7.67	(5.82)	21.14
VIGL	4.14	(0.31)	0.00	(0.06)	0.00	0.00	9.25	(9.04)	30.95
CNTB	3.99	(0.27)	0.00	(0.05)	0.00	0.00	8.47	(7.75)	48.67
ABOS	4.23	(0.15)	0.03	0.07	4.31	(5.24)	9.91	(7.43)	24.99
ETON	1.81	0.69	0.26	0.86	1.55	(2.26)	6.82	(2.33)	12.22
NUVB	3.12	(0.15)	(0.03)	0.01	3.65	(3.57)	6.98	(6.19)	17.51
ELDN	2.80	0.01	(0.01)	0.13	3.04	(3.39)	6.85	(4.92)	19.36
VRNA	3.22	0.83	0.30	0.49	2.80	(3.96)	8.31	(6.27)	25.38

Verrica Pharmaceuticals Corporate Management

Eugene Scavola	Executive Operations	Profile
Terence Kohler	Chief Officer	Profile
Dr MBA	Head Development	Profile
Christopher Hayes	Secretary, Officer	Profile
Joe Bonaccorso	Chief Commercial Officer	Profile
Gary MD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC